Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis The Pandemic’s Impact on Cancer Screening and Detection Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk. by Kevin McLaughlin Forward Look Cancer Treatments and Antioxidant Supplements Can Be a Bad Mix Christine Ambrosone on what her research shows. by Sue Rochman Forward Look Here Come the Biosimilars As patents expire on biologic drugs, cancer patients get new options. by Stephen Ornes Forward Look More Treatments Approved for Metastatic Breast Cancer Targeted therapy approvals increase options and hope for some patients. by Cameron Walker Q&A Taking the Long View In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy. by Marci A. Landsmann Why Skip a Dose? A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence. by Emma Yasinski Facing Cancer and a Pandemic at the Same Time Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other. by Jen Tota McGivney Virtual Connection in a Time of Social Distance Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones. by Marci A. Landsmann next Cancer Talk Cancer Diagnoses and Research Continue Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer. by Kevin McLaughlin Planning to Survive Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment. by Carly Flumer Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Cervical Cancer Screening Guideline Updated A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method. by Anna Azvolinsky More Posts